SCHEMBL18308342

SCHEMBL18308342

COc1ccccc1Cc1nnc2cnc3cc(/C(C(C)=N)=C(\C)O)c(OC)cc3n12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ASPH Q12797 1/20 0.35
▸ KDM8 Q8N371 1/20 0.35
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ GABRA4 P48169 1/20 0.33
▸ GABRE P78334 1/20 0.33
▸ GABRA6 Q16445 1/20 0.33
▸ GABRG1 Q8N1C3 1/20 0.33
▸ GABRG3 Q99928 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308505 0.93 MAPT (0.34) PDE2AMAPTKDM4EASPHKDM8
SCHEMBL18308325 0.92 KDM4E (0.35) PDE2AMAPTKDM4EMETALDH1A1
SCHEMBL18308537 0.91 MAPT (0.36) MAPTKDM4EMETPLK1ALDH1A1
SCHEMBL18308509 0.90 PLK1 (0.38) MAPTPLK1RAB9ANPC1ALDH1A1
SCHEMBL18308334 0.88 MAPT (0.33) MAPT
SCHEMBL18308539 0.88 MET (0.37) MAPTKDM4EMETALDH1A1LMNA
SCHEMBL18308323 0.86 IDH1 (0.34) MAPTKDM4EMETALDH1A1LMNA
SCHEMBL18308344 0.85 KIT (0.36) MAPTKDM4EMETLMNAGAA
SCHEMBL18308331 0.85 RECQL (0.35) MAPTALDH1A1LMNAGAA
SCHEMBL18308333 0.84 LCK (0.32) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016199943-A1 HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-12-15 — — WO disclosed
Send feedback